ScholarIQanswers from OpenAlex & ORCID
Axel Heidenreich
ResearcherPublications, citations & collaboration network
Axel Heidenreich is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Axel Heidenreich have?
ScholarIQindexed works
Axel Heidenreich has 1,463 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Axel Heidenreich have?
ScholarIQcitation count
Axel Heidenreich has 39,933 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Axel Heidenreich?
ScholarIQh-index
Axel Heidenreich has an h-index of 92 in OpenAlex.
What is the i10-index of Axel Heidenreich?
ScholarIQi10-index
Axel Heidenreich has an i10-index of 416 in OpenAlex.
What is the ORCID of Axel Heidenreich?
ScholarIQorcid
The ORCID for Axel Heidenreich is on the source record.
What is the OpenAlex record for Axel Heidenreich?
ScholarIQopenalex
The OpenAlex for Axel Heidenreich is on the source record.
What are the most-cited papers on Axel Heidenreich?
ScholarIQmost cited works
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Alberto Bossi, Robert G. Bristow, Brett S. Carver, Daniel Castellano, Byung Ha Chung, Noel W. Clarke, Gedske Daugaard, Ian D. Davis, Johann S. de Bono, Rodolfo Borges dos Reis, Charles G. Drake, Rosalind A. Eeles, Eleni Efstathiou, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Karim Fizazi, Mark Frydenberg, Martin Gleave, Susan Halabi, Axel Heidenreich, Celestia S. Higano, Nicolas James, Philip W. Kantoff, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Gero Kramer, Chris Logothetis, Fernando Cotait Maluf, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Vedang Murthy, William Oh, Piet Ost, Anwar R. Padhani, Chris Parker, Colin C. Pritchard, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Oliver Sartor, Howard I. Scher, Avishay Sella, Neal D. Shore, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Ian F. Tannock, Bertrand Tombal, R. Valdagni, Thomas Wiegel, Aurelius Omlin
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder
Georgios Gakis, Jason A. Efstathiou, Seth P. Lerner, Michael S. Cookson, Kirk A. Keegan, Khurshid A. Guru, William U. Shipley, Axel Heidenreich, Mark Schoenberg, Arthur I. Sagaloswky, Mark S. Soloway, Arnulf Stenzl
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial
Matthew R. Smith, Chris Parker, Fred Saad, Kurt Miller, Bertrand Tombal, Quan Sing Ng, Martin Boegemann, Vsevolod Matveev, Josep M. Piulats, Luis Eduardo Rosa Zucca, Oleg Karyakin, Go Kimura, Nobuaki Matsubara, William Carlos Nahas, Franco Nolè, Eli Rosenbaum, Axel Heidenreich, Yoshiyuki Kakehi, Amily Zhang, Heiko Krissel, Michael Teufel, Junwu Shen, Volker Jean Wagner, Celestia S. Higano
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Alberto Bossi, Alberto Briganti, Robert G. Bristow, Kim N., Noel W. Clarke, Ian D. Davis, Johann S. de Bono, Charles G. Drake, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Karim Fizazi, Mark Frydenberg, Martin Gleave, Susan Halabi, Axel Heidenreich, Daniel Heinrich, Celestia S. Higano, Michael S. Hofman, Maha Hussain, Nicholas D. James, Ravindran Kanesvaran, Philip W. Kantoff, Raja B. Khauli, Raya Leibowitz‐Amit, Chris Logothetis, Fernando Cotait Maluf, Robin Millman, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Hind Mrabti, Declan G. Murphy, Vedang Murthy, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Chris Parker, Darren M.C. Poon, Colin C. Pritchard, Robert E. Reiter, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Neal D. Shore, Eric J. Small, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Mary-Ellen Taplin, Bertrand Tombal, Levent Türkeri, Inge M. van Oort, A. Zapatero, Aurelius Omlin
Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer
Howard I. Scher, Xiaoyu Jia, Kim Chi, Ronald de Wit, William R. Berry, Peter Albers, Brian S. Henick, David Waterhouse, Dean Ruether, Peter J. Rosen, Anthony A. Meluch, Luke T. Nordquist, Peter Venner, Axel Heidenreich, Luis Chu, Glenn Heller